Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $33.24 in the prior trading day, Healthstream Inc (NASDAQ: HSTM) closed at $26.82, down -19.31%. In other words, the price has decreased by -$19.31 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HSTM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.17. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 03, 2024, initiated with a Overweight rating and assigned the stock a target price of $32.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 27 ’25 when Fenstermacher Scott sold 2,000 shares for $33.15 per share. The transaction valued at 66,300 led to the insider holds 12,327 shares of the business.
Taylor Tate Deborah sold 1,400 shares of HSTM for $39,938 on Aug 29 ’24. The Director now owns 22,326 shares after completing the transaction at $28.53 per share. On Aug 26 ’24, another insider, Fenstermacher Scott, who serves as the Senior Vice President of the company, sold 1,000 shares for $28.99 each. As a result, the insider received 28,990 and left with 12,008 shares of the company.
Valuation Measures:
As of this moment, Healthstream’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.03, and their Forward P/E ratio for the next fiscal year is 37.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.80 while its Price-to-Book (P/B) ratio in mrq is 2.27.
Stock Price History:
Over the past 52 weeks, HSTM has reached a high of $34.24, while it has fallen to a 52-week low of $26.58. The 50-Day Moving Average of the stock is -16.71%, while the 200-Day Moving Average is calculated to be -13.33%.
Shares Statistics:
A total of 30.53M shares are outstanding, with a floating share count of 24.17M. Insiders hold about 20.81% of the company’s shares, while institutions hold 75.78% stake in the company.
Earnings Estimates
The current assessment of Healthstream Inc (HSTM) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.18, with high estimates of $0.2 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.79 and $0.66 for the fiscal current year, implying an average EPS of $0.71. EPS for the following year is $0.78, with 3.0 analysts recommending between $0.86 and $0.71.
Revenue Estimates
5 analysts predict $75.09M in revenue for the current quarter. It ranges from a high estimate of $75.64M to a low estimate of $74.28M. As of the current estimate, Healthstream Inc’s year-ago sales were $71.56MFor the next quarter, 5 analysts are estimating revenue of $76.51M. There is a high estimate of $77.3M for the next quarter, whereas the lowest estimate is $75.9M.
A total of 5 analysts have provided revenue estimates for HSTM’s current fiscal year. The highest revenue estimate was $305.04M, while the lowest revenue estimate was $300.6M, resulting in an average revenue estimate of $303.84M. In the same quarter a year ago, actual revenue was $291.65MBased on 6 analysts’ estimates, the company’s revenue will be $320.14M in the next fiscal year. The high estimate is $322.3M and the low estimate is $317.5M.
